HK Stock Market Move | DALIPAL HLDG (01921) rose more than 4% during trading. Shareholders' net profit for 25 years is 13.723 million yuan. Investments in domestic and foreign energy exploration have increased.
Dali Pu Holdings (01921) rose more than 4% during the trading day. As of the time of writing, it has increased by 2.79%, trading at 7.01 Hong Kong dollars, with a turnover of 13.4323 million Hong Kong dollars.
DALIPAL HLDG (01921) rose more than 4% during trading hours, and as of the time of writing, it rose 2.79% to HK$7.01, with a trading volume of HK$134.23 million.
On the news front, DALIPAL HLDG recently released its annual performance for the year ending December 31, 2025. The group achieved a revenue of RMB 3.463 billion, a year-on-year increase of 5.17%. The net profit attributable to equity shareholders of the company was RMB 13.723 million, turning a loss into a profit year-on-year; earnings per share were RMB 0.01.
The announcement stated that the increase in revenue was mainly due to an increase in investment in energy exploration both domestically and internationally, leading to a recovery in market demand, as well as an increase in sales volume greater than the decrease in sales prices.
Related Articles

Toread Holdings Group (300005.SZ): The application for the issuance of A-shares to specific investors in the 2025 fiscal year has been accepted by the Shenzhen Stock Exchange.

New stock news | Miliantech submits application to HKEX, leading the way in the ten billion emotional social networking track.

Anhui Anke Biotechnology (300009.SZ) appoints Dou Changlin as the company's Chief Executive Officer and Chief Scientist.
Toread Holdings Group (300005.SZ): The application for the issuance of A-shares to specific investors in the 2025 fiscal year has been accepted by the Shenzhen Stock Exchange.

New stock news | Miliantech submits application to HKEX, leading the way in the ten billion emotional social networking track.

Anhui Anke Biotechnology (300009.SZ) appoints Dou Changlin as the company's Chief Executive Officer and Chief Scientist.






